logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Chengyong Tang

bishan hospital of chongqing medical university

2H指数
14论文数
15被引数
收录论文 9
发表时间
logo
First-In-Human Study of Mirogabalin (BM2216) Sustained-Release Tablets: Safety, Tolerability, Pharmacokinetics, Food Effect and Dose Proportionality With Comparison to Mirogabalin Besylate in Healthy Participants首次人体研究：米罗加巴林（BM2216）缓释片的安全性、耐受性、药代动力学、食物效应和剂量比例性，并与米罗加巴林苯磺酸盐进行比较（健康受试者）
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-09-02
err0
errOAAI
errPeiyang Song; Hongtao Zhao; Mingxue Zhu; Lei Wan; Yuan Chen; Zhongping Li; Chengyong Tang
err分享
err收藏
Pharmacokinetics, bioequivalence, and safety of two formulations of Toremifene citrate tablets in healthy Chinese participants under fasted and fed conditions枸橼酸他莫昔芬片两种剂型的药代动力学、生物等效性和安全性研究：空腹及餐后条件下在中国健康受试者中的比较
errScientific Reports
IF3.9
err2026-08-06
err0
errOAAI
errPeiyang Song; Lei Wan; Hongtao Zhao; Mingxue Zhu; Zhongping Li; Yuan Chen; Chengyong Tang
err分享
err收藏
Front Cover封面
errdiabetes obesity metabolism
IF0
err2025-09-03
err0
errOAAI
errJunliang Pu PhD; Yurui Huang BS; Lei Wan MM; Mingxue Zhu MM; Huili Wei PhD; Hong Gao PhD; Liping Zhong MS; Chengyong Tang PhD; Junfang Xu PhD
err分享
err收藏
First-in-human study of HDM1002, a GLP-1 receptor agonist: Safety, tolerability, pharmacokinetics and pharmacodynamics of escalating single oral doses in healthy volunteersHDM1002（一种GLP-1受体激动剂）首次人体研究：健康受试者中递增单次口服剂量的安全性、耐受性、药代动力学和药效学研究
errdiabetes obesity metabolism
IF0
err2025-07-15
err0
PREAI
errJunliang Pu PhD; Yurui Huang BS; Lei Wan MM; Mingxue Zhu MM; Huili Wei PhD; Hong Gao PhD; Liping Zhong MS; Chengyong Tang PhD; Junfang Xu PhD
err分享
err收藏
Pharmacokinetics, Pharmacodynamics, and Bioequivalence of Test Insulin Glargine Versus Reference Preparation (Lantus®) in Healthy Male Volunteers-By Euglycemic Clamp Technique试验用胰岛素甘精注射液与参比制剂（Lantus®）在健康男性志愿者中的药代动力学、药效动力学及生物等效性研究——采用血糖正常钳夹技术
errPHARMACEUTICS
IF5.5
err2025-03-25
err0
errOAAI
errLi, Zhongping; Liu, Min; Tao, Yi; Wan, Lei; Chen, Yuan; Zhu, Mingxue; Zhao, Hongtao; Tang, Chengyong
err分享
err收藏
Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog®25) in Chinese healthy male volunteers胰岛素lispro 25与原始制剂(Humalog®25)在健康中国男性志愿者中的药代动力学和药效动力学研究
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-02-25
err0
errOAAI
errZhu, Mingxue; Chen, Yuan; Wan, Lei; Li, Zhongping; Pu, Junliang; Tang, Chengyong
err分享
err收藏
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial每周一次的新型基础胰岛素GZR4在健康参与者中的安全性，耐受性，药代动力学和药效学: 一项随机试验
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-02-11
err0
PREAI
errTang, Chengyong; Su, Rui; Wan, Lei; Zhu, Mingxue; Pu, Junliang; Hao, Chunyue; Zhao, Jing; He, Anshun; Xie, Tian; Li, Yue; Chen, Wei; Gan, Zhong-Ru
err分享
err收藏
Study on bioequivalence and influence of obesity-related indicators on pharmacokinetics and pharmacodynamics for insulin degludec in healthy subjects胰岛素的生物等效性及肥胖相关指标对健康受试者药代动力学和药效学影响的研究
errSCIENTIFIC REPORTS
IF3.9
err2024-10-21
err1
errOAAI
errSu, Rui; Wan, Lei; Tao, Yi; Zhu, Mingxue; Pu, Junliang; Li, Zhongping; Chen, Yuan; Tang, Chengyong
err分享
err收藏
Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center烧伤中心鲍曼不动杆菌 β-内酰胺酶基因多位点序列分型及分子特征分析
errBURNS
IF2.9
err2017-11-01
err7
PREAI
errHuang, Guangtao; Peng, Yuan; Yang, Yong; Tang, Chengyong; Fu, Yuexian
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
陈
陈伟 (Wei Chen)
H 指数: 60 · 论文数: 423
M
Min Liu
H 指数: 43 · 论文数: 414
Y
Yuan Peng
H 指数: 41 · 论文数: 248
Z
Zhongping Li
H 指数: 38 · 论文数: 190
L
Liping Zhong
H 指数: 36 · 论文数: 170
查看更多